TY - JOUR
T1 - Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization
AU - Thrivikraman, Greeshma
AU - Athirasala, Avathamsa
AU - Gordon, Ryan
AU - Zhang, Limin
AU - Bergan, Raymond
AU - Keene, Douglas R.
AU - Jones, James M.
AU - Xie, Hua
AU - Chen, Zhiqiang
AU - Tao, Jinhui
AU - Wingender, Brian
AU - Gower, Laurie
AU - Ferracane, Jack L.
AU - Bertassoni, Luiz E.
N1 - Funding Information:
Bone marrow-derived human sesenchymal stem cells were kindly donated by Dr Brian Johnstone. We thank Dr Eric Orwoll and Dr Jason Burdick for insight and expertise on bone and stem cell biology, respectively. We also thank Dr C. Lopez, Dr J. Riesterer, E Stempinski, and K Loftis for help with electron microscopy imaging/analysis performed at the Multiscale Microscopy Core (MMC) facility at OHSU. We thank Dr C. Chaw and Dr S. Kaech for the support with confocal imaging/analysis performed at the Advanced Light Microscopy (ALM) Core at OHSU. L.E.B. acknowledges funding from the NIH/ National Institute of Dental and Craniofacial Research (R01DE026170 to L.E.B.), American Academy of Implant Dentistry Foundation, OHSU-PSU Collaboration Project Seed funding and Cancer Early Detection Advanced Research-Knight Cancer Institute. J.T. acknowledges support from the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL). PNNL is a multiprogram national laboratory operated by Battelle for the U.S. Department of Energy (DOE) under Contract DE-AC05-76RL01830. L.G. acknowledges funding from the National Science Foundation under Grant Number (DMR-1309657).
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Bone tissue, by definition, is an organic–inorganic nanocomposite, where metabolically active cells are embedded within a matrix that is heavily calcified on the nanoscale. Currently, there are no strategies that replicate these definitive characteristics of bone tissue. Here we describe a biomimetic approach where a supersaturated calcium and phosphate medium is used in combination with a non-collagenous protein analog to direct the deposition of nanoscale apatite, both in the intra- and extrafibrillar spaces of collagen embedded with osteoprogenitor, vascular, and neural cells. This process enables engineering of bone models replicating the key hallmarks of the bone cellular and extracellular microenvironment, including its protein-guided biomineralization, nanostructure, vasculature, innervation, inherent osteoinductive properties (without exogenous supplements), and cell-homing effects on bone-targeting diseases, such as prostate cancer. Ultimately, this approach enables fabrication of bone-like tissue models with high levels of biomimicry that may have broad implications for disease modeling, drug discovery, and regenerative engineering.
AB - Bone tissue, by definition, is an organic–inorganic nanocomposite, where metabolically active cells are embedded within a matrix that is heavily calcified on the nanoscale. Currently, there are no strategies that replicate these definitive characteristics of bone tissue. Here we describe a biomimetic approach where a supersaturated calcium and phosphate medium is used in combination with a non-collagenous protein analog to direct the deposition of nanoscale apatite, both in the intra- and extrafibrillar spaces of collagen embedded with osteoprogenitor, vascular, and neural cells. This process enables engineering of bone models replicating the key hallmarks of the bone cellular and extracellular microenvironment, including its protein-guided biomineralization, nanostructure, vasculature, innervation, inherent osteoinductive properties (without exogenous supplements), and cell-homing effects on bone-targeting diseases, such as prostate cancer. Ultimately, this approach enables fabrication of bone-like tissue models with high levels of biomimicry that may have broad implications for disease modeling, drug discovery, and regenerative engineering.
UR - http://www.scopus.com/inward/record.url?scp=85070281056&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070281056&partnerID=8YFLogxK
U2 - 10.1038/s41467-019-11455-8
DO - 10.1038/s41467-019-11455-8
M3 - Article
C2 - 31388010
AN - SCOPUS:85070281056
SN - 2041-1723
VL - 10
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 3520
ER -